Clinical Trial: Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase 2/3, Multicenter, Multinational, Open Label Study to Evaluate the Efficacy and Safety of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A

Brief Summary: To evaluate the safety and efficacy of ALXN1101 in neonate patients with MoCD Type A